aTyr Pharma reported $2.28M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Ardelyx USD 256.19M 47.93M Jun/2026
aTyr Pharma USD 2.28M 478K Jun/2026
Biogen USD 7.69B 398.3M Sep/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Cipla INR 6.99B 857M Sep/2026
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 3.02M 91K Jun/2026
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
GlaxoSmithKline GBP 18.24B 818M Jun/2026
Grifols EUR 9.23B 626.05M Dec/2024
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
United Therapeutics USD 200M 100M Mar/2025